President Donald Trump unveiled new “Most Favored Nation” pricing deals with nine pharmaceutical companies, aiming to lower drug costs and reduce the burden on health insurance premiums. The agreements will allow these medications to be sold in the US at the lowest available price in peer countries.
The White House said that this program has become a centerpiece of the administration’s healthcare agenda, with companies agreeing to sell medicines to Medicaid at discounted prices and launch new medications in the US at the same rate. To make drugs more affordable for Americans, Trump also announced plans to create an online platform called TrumpRx where people can buy medications directly from manufacturers.
However, experts say that while these deals may benefit some patients, their impact on overall drug prices remains uncertain. Many are skeptical about how much Americans will actually save under the new agreements, as details of the deals remain scarce.
Source: https://edition.cnn.com/2025/12/19/politics/us-drug-prices-trump-nation-deals